Technical Analysis for TNGX - Tango Therapeutics
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Reached Overbought | Strength | 0.00% | |
Weak + Overbought | Other | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
20 DMA Support | Bullish | -2.69% | |
Crossed Above 50 DMA | Bullish | -2.69% | |
Expansion Pivot Buy Setup | Bullish Swing Setup | -2.69% | |
Pocket Pivot | Bullish Swing Setup | -2.69% | |
Crossed Above 20 DMA | Bullish | 7.24% | |
Pocket Pivot | Bullish Swing Setup | 7.24% |
Alert | Time |
---|---|
Possible NR7 | about 10 hours ago |
Expansion Pivot Buy Entry | about 12 hours ago |
Rose Above Previous Day's High | about 12 hours ago |
Down 1% | about 12 hours ago |
Up 1% | about 12 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
- Earnings date: 03/17/2025
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Biology Treatment Of Cancer Tumor Genetics Medical Genetics Applied Genetics Synthetic Lethality Oncogenomics
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Biology Treatment Of Cancer Tumor Genetics Medical Genetics Applied Genetics Synthetic Lethality Oncogenomics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 12.8 |
52 Week Low | 2.585 |
Average Volume | 1,047,045 |
200-Day Moving Average | 6.78 |
50-Day Moving Average | 3.19 |
20-Day Moving Average | 3.01 |
10-Day Moving Average | 3.10 |
Average True Range | 0.24 |
RSI (14) | 54.75 |
ADX | 12.88 |
+DI | 22.68 |
-DI | 15.00 |
Chandelier Exit (Long, 3 ATRs) | 2.92 |
Chandelier Exit (Short, 3 ATRs) | 3.31 |
Upper Bollinger Bands | 3.36 |
Lower Bollinger Band | 2.66 |
Percent B (%b) | 0.86 |
BandWidth | 23.27 |
MACD Line | -0.02 |
MACD Signal Line | -0.07 |
MACD Histogram | 0.052 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.56 | ||||
Resistance 3 (R3) | 3.58 | 3.49 | 3.51 | ||
Resistance 2 (R2) | 3.49 | 3.42 | 3.49 | 3.49 | |
Resistance 1 (R1) | 3.38 | 3.37 | 3.34 | 3.36 | 3.48 |
Pivot Point | 3.29 | 3.29 | 3.27 | 3.29 | 3.29 |
Support 1 (S1) | 3.18 | 3.22 | 3.14 | 3.16 | 3.04 |
Support 2 (S2) | 3.09 | 3.17 | 3.09 | 3.03 | |
Support 3 (S3) | 2.98 | 3.09 | 3.01 | ||
Support 4 (S4) | 2.96 |